… Inc., where he was lead crystallographer and core member of multiple drug discovery programs, including schizophrenia … in building and implementing fragment-based technologies in multiple organizations including Merck and Metabasis. He is …

… and the University of Nottingham (cognitive problems in multiple sclerosis), before returning to Kent for a … across projects on Parkinson’s disease, dementia, and multiple sclerosis. …

… Biomarkers …

… toward the clinic. Instead of targeting the dopamine system, his approach focuses on the glutamate system, which could match the benefit of levodopa without … idea of using mGluR4 for treatment of PD to a point where multiple pharmaceutical companies are now interested in …

… optimizing drug-like small molecules with CNS exposure for multiple sclerosis and Alzheimer’s disease therapeutics. She … for progressive supranuclear palsy (O-GlcNAcase inhibitor), multiple sclerosis and an oxytocin receptor antagonist that …

… Disease Research Center (ADRC). He is also PI of multiple projects regarding novel latent variable modeling … faculty statistician in numerous clinical trials and multiple Data and Safety Monitoring Boards. …